Virta Health 2019 Disruptor 50

More than 100 million people inside the U.S. live with diabetes or pre-diabetes, in addition to in which number is usually growing. Virta Health co-founder in addition to CEO Sami Inkinen decided to do something about in which. In 2011 the avid exerciser in addition to co-founder of the real estate listings company Trulia won his age group at the Ironman 70.3 World Championships. He also found out he had pre-diabetes. Disillusioned with the usual advice to lose weight, eat less in addition to exercise more (none were actually applicable to him), he decided to do his own research in addition to connected with Drs. Stephen Phinney in addition to Jeff Volek, experts on the science of carbohydrate restriction in addition to metabolic health.

Read More: FULL LIST 2019 DISRUPTOR 50

In 2014 Virta Health was launched with the goal of reversing type 2 diabetes in 100 million people by 2025. At the core of the company is usually the Virta Treatment plan. This kind of offers patients continuous medical supervision, personalized dietary guidance in addition to health coaching, supplies in addition to biomarker tracking. having a high-fat, low carbohydrate diet, combined with regular monitoring in addition to coaching, the company claims This kind of has sustained type 2 diabetes reversal in 60% of the patients who completed the treatment after one year in addition to 94% of patients saying they had reduced or fully eliminated their insulin usage.

The Virta Treatment plan costs $370 per month (after a one-time $500 initiation fee), nevertheless an increasing number of employers in addition to health plans are picking up the costs for those individuals enrolled. So confident is usually Virta in which its treatment type works, the company announced a completely new payment type for its institutional customers last year. Health insurers in addition to self-insured companies only have to pay for patients on the program who have increased health outcomes.

So far, Virta has raised $82 million, including a $45 million Series B round by investors including Venrock, Obvious Ventures in addition to Founders Fund.